Overlapping Chronic Pain and Depression: Pathophysiology and Management
Publisher
Springer Singapore
Reference119 articles.
1. Amidfar M, Khiabany M, Kohi A, Salardini E, Arbabi M, Roohi Azizi M, Zarrindast MR, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. J Clin Pharm Ther. 2017;42(1):44–50. 2. Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, Gitelman DR. Chronic back painPain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24:10410–5. 3. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of painPain perception and regulation in health and disease. Eur J Pain. 2005;9:463–84. 4. Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR painPain disorder. Eur J Pain. 2005;9:33–8. 5. Arnold LM, Palmer RH, Ma Y. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia. Clin J Pain. 2013;29:1021–8.
|
|